LCP1 and cancer: Phosphorylation on residue serine-5 (Ser5), the major L-plastin phosphorylation site [22]–[24], has been shown to increase its F-actin-binding and -bundling activities in vitro and to be required for efficient targeting of L-plastin to focal adhesion sites as well as for cancer cell invasion [8], [9].